Z6尊龙
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2017.11.11
中国证监会行政允许项目审查一次反响意见通知书
2017.11.07
“16Z6尊龙”2017年付息通告
2017.10.26
关于全资孙公司通过美国FDA现场检查的通告
2017.10.21
关于控股子公司临床试验希望的通告
2017.10.19
关于收到《中国证监会行政允许申请受理通知书》的通告
2017.10.14
第四届董事会第七次聚会决议通告
2017.10.14
关于使用自有资金对Resverlogix Corp.举行投资的通告
2017.10.12
关于延期向中国证监会报送重组申请质料的通告
2017.10.11
关于公司使用自有资金购置低危害理工业品的希望通告
2017.09.30
2017年第四次暂时股东大会的执法意见书
第一页
上一页
63
64
65
66
67
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
【网站地图】
【sitemap】